Common diabetes pill may stop mouth cancer before it starts

NCT ID NCT05237960

Ongoing Prevention Sponsor: University of Arizona Source: ClinicalTrials.gov ↗

Summary

This study is testing if metformin, a common diabetes medication, can prevent oral cancer in people who have suspicious red or white patches in their mouth. About 34 adult smokers or former smokers with these pre-cancerous patches will take either metformin or a placebo pill daily for 24 weeks. Researchers will check if the patches shrink or improve, aiming to see if this affordable, existing drug can stop cancer from developing.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

British Columbia Cancer Agency

Vancouver, British Columbia, V5Z 4E6, Canada
Dalhousie University

Halifax, Nova Scotia, B3H 4R2, Canada
Emory University Hospital/Winship Cancer Institute

Atlanta, Georgia, 30322, United States
Louisiana State University

Lafayette, Louisiana, 70503, United States
Moffitt Cancer Center

Tampa, Florida, 33612, United States
NYU College of Dentistry

New York, New York, 10010, United States
UC San Diego Medical Center - Hillcrest

San Diego, California, 92103, United States
University of Arizona Cancer Center-North Campus

Tucson, Arizona, 85719, United States
University of Michigan Comprehensive Cancer Center

Ann Arbor, Michigan, 48109, United States
University of Minnesota/Masonic Cancer Center

Minneapolis, Minnesota, 55455, United States

Conditions

Explore the condition pages connected to this study.

ERYTHROPLAKIA ORAL LEUKOPLAKIA